Pfizer Inc is of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of CERE, which is worth approximately $0. The most recent transaction as insider was on Aug 01, 2024, when has been sold 27,349,211 shares (Common Stock) at a price of $45.0 per share, resulting in proceeds of $1,230,714,495. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

PFIZER INC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2024
SELL
Disposition due to a tender of shares in a change of control transaction
$1,230,714,495 $45.0 p/Share
27,349,211 Reduced 100.0%
0 Common Stock
Oct 27 2020
BUY
Open market or private purchase
$12,000,000 $10.0 p/Share
1,200,000 Added 4.2%
27,349,211 Common Stock

Also insider at

VTRS
Viatris Inc Healthcare
ICUI
ICU MEDICAL INC Healthcare
ALLO
Allogene Therapeutics, Inc. Healthcare
SWTX
SpringWorks Therapeutics, Inc. Healthcare
BCAB
BioAtla, Inc. Healthcare
PYXS
Pyxis Oncology, Inc. Healthcare
CRTX
Cortexyme, Inc. Healthcare
IMRA
IMARA Inc. Healthcare
PI

Pfizer Inc

New York, NY

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Track Activities on CERE